September 21. 2010 SFS Technology at SPIE Security+Defence '10

NarTest Founder and R&D Director Larisa Poryvkina hosted a poster session on submitted scientific paper "Detection of illicit drugs with the technique of Spectral Fluorescence Signatures (SFS)" at SPIE Security+Defence 2010 conference held in Toulouse, France.
SFS technology for drug detection is an underlying method for NarTest NTX2000 portable drug analyzer that can rapidly detect very low concentrations of drugs in seized street samples and conclusively identify the controlled substance in question.

NarTest is a privately owned company with offices in US and EU that develops innovative drug identification solutions for law enforcement agencies worldwide.

SPIE, the international society for optics and photonics, was founded in 1955 to advance light-based technologies. Serving more than 180,000 constituents from 168 countries, the Society advances emerging technologies through interdisciplinary information exchange, continuing education, publications, patent precedent, and career and professional growth. SPIE annually organizes and sponsors approximately 25 major technical forums, exhibitions, and education programs in North America, Europe, Asia, and the South Pacific, and supports scholarships, grants, and other education programs around the world.


Further info:

Martin Ruubel
info@nartest.com
+1 866 874 6917
+44 20 3290 9977